15 June 2020
We are delighted to welcome Advanced Accelerator Applications(AAA) as a BIR corporate member. AAA develops targeted radioligand therapies and precision imaging radioligands for oncology. As a platinum sponsor, AAA will be a prominent supporter of our education programme and we look forward to collaborating to provide support to our nuclear medicine community.
Dr Jane Phillips-Hughes, President of the BIR said “We are delighted to welcome AAA to our community and look forward to collaborating and learning more about the innovation and best practice in nuclear medicine and radioisotope imaging.”
Jeevan Virk, General Manager of AAA said “As pioneers in the use of radioisotopes for both imaging and treatment of advanced cancers, we are proud to support BIR.”
image: Jeevan Virk, General Manager, AAA.
